L g Spivak - JoVE Visualize

Showing results (11-20 of 30) with videos related to

Pageof 3

Sort By:

Urologiia (Moscow, Russia : 1999)|December 16, 2015

[REVIEW OF CLINICAL STUDIES ON COMBINATION THERAPY OF 5α-REDUCTASE INHIBITORS AND α1-BLOCKERS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA]L G Spivak, K L Lokshin, A Z Vinarov

Urologiia (Moscow, Russia : 1999)|September 28, 2017

[Experience of using phytolysin in combination therapy of chronic cystitis in patients with urate nephrolythisis]L G Spivak, D V Enikeev, D V Platonova

Urologiia (Moscow, Russia : 1999)|September 20, 2019

[Medical treatment of patients with benign prostatic hyperplasia with 5-reductase inhibitors]L G Spivak, D V Platonova, D D Yagudaev

Urologiia (Moscow, Russia : 1999)|September 28, 2017

[Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines]A Z Vinarov, L G Spivak, A V Mironov

Urologiia (Moscow, Russia : 1999)|August 11, 2012

[Treatment of chronic prostatitis in prophylaxis of prostatic adenoma]Iu G Aliaev, A Z Vinarov, Iu L Demidko, et al.

Urologiia (Moscow, Russia : 1999)|March 7, 2002

[Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)]Iu G Aliaev, A Z Vinarov, K L Lokshin, et al.

The Laryngoscope|October 1, 1994

Programming the cochlear implant based on electrical acoustic reflex thresholds: patient performanceL G Spivak, P M Chute, A L Popp, et al.

Urologiia (Moscow, Russia : 1999)|October 29, 2013

[The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia]Iu G Aliaev, A Z Vinarov, Iu L Demidko, et al.

Urologiia (Moscow, Russia : 1999)|March 23, 2006

[Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis]Iu G Aliaev, A Z Vinarov, K L Lokshin, et al.

Urologiia (Moscow, Russia : 1999)|July 4, 2023

[Efficiency and safety of Prostatex in patients with chronic prostatitis/chronic pelvic pain syndrome. Results of the phase IV PRESTIGE trial]A O Morozov, S V Vovdenko, P Sh Maltsagova, et al.

Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:

Pageof 3

Urologiia (Moscow, Russia : 1999)|December 16, 2015

[REVIEW OF CLINICAL STUDIES ON COMBINATION THERAPY OF 5α-REDUCTASE INHIBITORS AND α1-BLOCKERS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA]L G Spivak, K L Lokshin, A Z Vinarov

Urologiia (Moscow, Russia : 1999)|September 28, 2017

[Experience of using phytolysin in combination therapy of chronic cystitis in patients with urate nephrolythisis]L G Spivak, D V Enikeev, D V Platonova

Urologiia (Moscow, Russia : 1999)|September 20, 2019

[Medical treatment of patients with benign prostatic hyperplasia with 5-reductase inhibitors]L G Spivak, D V Platonova, D D Yagudaev

Urologiia (Moscow, Russia : 1999)|September 28, 2017

[Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines]A Z Vinarov, L G Spivak, A V Mironov

Urologiia (Moscow, Russia : 1999)|August 11, 2012

[Treatment of chronic prostatitis in prophylaxis of prostatic adenoma]Iu G Aliaev, A Z Vinarov, Iu L Demidko, et al.

Urologiia (Moscow, Russia : 1999)|March 7, 2002

[Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)]Iu G Aliaev, A Z Vinarov, K L Lokshin, et al.

The Laryngoscope|October 1, 1994

Programming the cochlear implant based on electrical acoustic reflex thresholds: patient performanceL G Spivak, P M Chute, A L Popp, et al.

Urologiia (Moscow, Russia : 1999)|October 29, 2013

[The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia]Iu G Aliaev, A Z Vinarov, Iu L Demidko, et al.

Urologiia (Moscow, Russia : 1999)|March 23, 2006

[Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis]Iu G Aliaev, A Z Vinarov, K L Lokshin, et al.

Urologiia (Moscow, Russia : 1999)|July 4, 2023

[Efficiency and safety of Prostatex in patients with chronic prostatitis/chronic pelvic pain syndrome. Results of the phase IV PRESTIGE trial]A O Morozov, S V Vovdenko, P Sh Maltsagova, et al.

Pageof 3